BioStem Tech
BSEM1.6153.87% ( -0.065 )
BioStem Tech (BSEM)
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenera...
- Open
- 1.670
- High
- 1.670
- Low
- 1.600
- Prev. Close
- 1.680
- Volume
- 11.45K
- Turnover
- 18.97K
- Avg Price
- 1.657
- Bid/Ask Ratio
- 37.50%
- Amplitude
- 4.17%
- 52wk High
- 5.440
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.08%
- 52wk Low
- 1.450
- Float Mkt Cap
- 22.92M
- Market CapUSD
- 30.01M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.52
- EPSDynamic
- -1.91
- EPSStatic
- --
- BVPS
- 1.49
- P/B
- 1.09
- Circulating Supply
- 14.19M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 18.58M
- Min lot size
- 1
- Currency
- USD
BioStem Tech Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$7.00333.44%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report ·
Selective Institutional Bets Emerge in Medical and Tech Niches
- PUBT ·
BioStem wins US patent for sterile human placental allografts, methods of making them
- TradingView ·
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants
- PUBT ·
BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rules
